- Bevorzugter Name
- Tak-593
- IUPAC
- N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide
- Englischer Name
- TAK-593
- Summenformel
- C23H23N7O3
- Molmasse
- 445.47
Namen und Synonyme
TAK-5931005780-62-0TAK 593H3I42X8XX71H-Pyrazole-5-carboxamide, N-(5-((2-((cyclopropylcarbonyl)amino)imidazo(1,2-b)pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-N-[5-({2-cyclopropaneamidoimidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamideTAK593N-(5-((2-cyclopropaneamidoimidazo(1,2-b)pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamideRefChem:187192VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593UNII-H3I42X8XX7N-(5-((2-(cyclopropanecarboxamido)imidazo[1,2-b]pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide
Weitere Namen anzeigen
TAK-593, 10 mM in DMSO1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-Platelet-derived growth factor receptor,VEGFR,PDGFR,Inhibitor,TAK 593,inhibit,TAK593,TAK-593,Vascular endothelial growth factor receptor
CHEMBL2180604N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-;1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-orb1219200orb1307706SCHEMBL2515478DZFZXPPHBWCXPQ-UHFFFAOYSA-NC23H23N7O3